The trend: Funding for insurtech firms in the third quarter of 2022 fell to its lowest level in more than two years amid a wider slowdown for insurance investment and deals.
CB Insights’ Q3 State of Insurtech report found that:
What this means: Much like funding and deals for fintechs, the insurtech market has entered a period of consolidation characterized by sliding valuations and a harsher funding climate. This could mean that weaker insurtechs will struggle to raise investments while others are forced into down rounds. Companies must prove the sustainability of their business models if they are to attract financial backers and some will have to trim costs and downgrade their plans to avoid raising cash.
However, the drop in deals, lower valuations, and decrease in funding rounds could prove to be the ideal climate for firms eyeing insurtech acquisitions at a bargain. Expect to see deals in the next year as companies armed with healthy cash reserves look for cut-price insurtechs to buy.
The bottom line: Insurtechs will look to narrow costs to weather the ongoing economic storm. Those that can’t may have to seek funding; and some weaker firms will inevitably not survive.
However, that presents opportunities for strong companies. Some that raised money at realistic valuations over the last couple of years won’t be greatly affected. Looking ahead, though deals and funding could easily drop further, the insurance sector is in better health than many others in the face of the looming global recession.
This article originally appeared in Insider Intelligence’s Banking Innovation Briefing—a daily recap of top stories reshaping the banking industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.
11 Times SquareNew York, NY 100361-800-405-0844